Global Human Microbiome Sequencing Market to Reach $6.33 Billion by 2029, Reports BIS Research

According to a new market intelligence report by BIS Research, titled “Global Human Microbiome Sequencing Market – Analysis and Forecast: 2019-2029”, the market for human microbiome sequencing is anticipated to clock a CAGR of 19.44% during the forecast period 2019-2029. As high-throughput approaches continue to advance and become clinically corroborated, it is expected that next-generation sequencing will be at the forefront as a method for understanding host-microbiome relationships, leading to a highly flourishing human microbiome sequencing market. The market is expected to grow up to $6.33 billion by the end of 2029.

Although at its nascency, the human microbiome has progressively become an inseparable part of human health owing to the increasing number of global initiatives establishing its symbiotic role in the upkeep of human health. While probiotic-based products have already made their entry into the market, primarily based on the historical research profiling general human gut microbiota, global initiatives are now being undertaken to emphasize the role of the human microbiome as a “second genome”. Large-scale sequencing studies, attempting to replicate the global genome sequencing initiatives, have delved deeper into understanding human microbiome variation across demographics.

Browse BIS Research Report: https://bisresearch.com/industry-report/human-microbiome-sequencing-market.html

The central role of the gut microbiota in modulating human health has further expanded into understanding its role in modulating other metabolic factors in the human body. As a result, human microbiome sequencing has become the centerpiece of an ever-evolving precision medicine landscape. Growing interests across the healthcare continuum worldwide have rendered a highly dynamic market, dotted with mushrooming start-ups that have disrupted testing accessibility. Further, growing adoption among the global population has also facilitated enormous growth and will continue to propel the overall market.

According to Nitish Kumar Singh, Principal Analyst at BIS Research, “Disease diagnosis is expected to remain the leading application by the end of 2029. Disease diagnosis contributed to 41.95% of the market revenue in 2018 and is anticipated to hold a 37.10% share of the market in 2029. However, consumer wellness is expected to be the fastest-growing application, far outpacing the likes of drug discovery and omics analysis.”

Research Highlights:
• Leading players in the global human microbiome sequencing market focus on undertaking synergistic activities with emerging start-ups in order to further expand their product portfolio.
• The funding and business expansion scenario in the global human microbiome sequencing market has been a tremendous driving factor in bolstering the overall market. With the aim of advancing research through investments, legacy healthcare companies have invested significantly in start-ups to aid in product commercialization.

Request for Sample Report: https://bisresearch.com/requestsample?id=858&type=download

This market intelligence report provides a multidimensional view of the global human microbiome sequencing market in terms of market size and growth potential. This research report aims at answering various aspects of the human microbiome sequencing market with the help of key factors driving the market, threats that can inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion.

Furthermore, the competitive landscape chapter in the report explicates the competitive nature of the global market and enables the reader to get acquainted with the recent market activities such as M&A activities, regulatory and legal activities, partnerships, and alliances, and business expansion activities. The research report provides a comprehensive analysis of sales value and manufacturers, and trend analysis by segment, and demand analysis by region.

This report is a meticulous compilation of research on more than 15 players in the market ecosystem and draws upon insights from in-depth interviews with the key opinion leaders of the leading companies, market participants, and vendors.

Key USPs of the Report
• The industry analysis encompasses patent analysis, regulatory landscape, and awaited technological developments. The patent analysis section covers the current trends and analyzes their growing impact on the market. This section aids the readers in staying updated with the latest regulations as well as discuss how the market is likely to unfold during the next 10 years.
• The market share analysis includes key insights on the revenue share of the players operating in the market, both for manufacturers and service providers. It provides information on who the leading players in the market are. It also includes growth-share analyses of the key players and key applications in the study.
• The key strategies and developments highlight the information on the recent developments in the market, which includes the following categories - funding activities, M&A activities, partnerships, alliances & business expansions, regulatory & legal, new offerings, and procurement & sales.

In addition, the report provides a detailed analysis and growth forecast for each segment in the subsequent sections. Country-wise analysis has been provided for 17 leading countries across the globe. Some of the key players contributing to the global human microbiome sequencing market include Baseclear B.V., BGI Genomics, Charles River Laboratories International Inc., Clinical Microbiomics A/S, Eurofins Scientific SE, GENEWIZ, Inc., Illumina, Inc., Novogene Corporation, OraSure Technologies, Inc., Oxford Nanopore Technologies, Inc., Pacific Biosciences of California, Inc., QIAGEN N.V., Second Genome, Inc., Thermo Fisher Scientific Inc., Viome, Inc., CosmosID, Leucine Rich Bio Pvt. Ltd., Microba, Microbiome Insights Inc., and Molzym GmbH, among others.

Key Questions Answered in the Report:
• What are the long-term and short-term impacts of human microbiome sequencing on the human health continuum?
• What are the major market drivers, challenges, and opportunities in the global human microbiome sequencing market?
• What are the key development strategies that are implemented by the major players in order to sustain in the competitive market?
• What are the key regulatory implications in developed and developing regions for the global human microbiome sequencing market?
• How is the patent landscape in the industry shaping up future technological trends?
• How is each segment of the market expected to grow during the forecast period from 2019 to 2029?
• Who are the leading players with significant offerings to the global human microbiome sequencing market? What is the expected market dominance for each of these leading players?
• Which companies are anticipated to be highly disruptive in the future, and why?
• What are challenges that are yet to be met by the global human microbiome sequencing market?

Contact:
Bhavya Banga
Email: media@bisresearch.com
BIS Research Inc.
39111 PASEO PADRE PKWY STE 313,
FREMONT CA 94538-1686
Visit our Blog @ https://blog.bisresearch.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research
Connect with us on Twitter@ https://twitter.com/BISResearch

About BIS Research

BIS Research is a global B2B market intelligence and advisory firm focusing on those emerging technological trends which are likely to disrupt the dynamics of the market.
With over 150 market research reports published annually, BIS Research focuses on high technology verticals such as 3D Printing, Advanced Materials and Chemicals, Aerospace and Defense, Automotive, Healthcare, Electronics and Semiconductors, Robotics and UAV, and other emerging technologies.
Our in-depth market intelligence reports focus on market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.
What distinguishes BIS Research from the rest of the players is that we don’t simply provide data but also complement it with valuable insights and actionable inputs for the success of our clients.

This release was published on openPR.